Fingerprint
Dive into the research topics of 'Simvastatin increases the in vivo activity of the first-line tuberculosis regimen'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Simvastatin increases the in vivo activity of the first-line tuberculosis regimen
Ciaran Skerry, Michael L. Pinn, Natalie Bruiners, Richard Pine, Maria L. Gennaro, Petros C. Karakousis
Research output: Contribution to journal › Article › peer-review
54
Scopus
citations